Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback